Search result for 'senores pharmaceuticals'

Senores Pharmaceuticals will acquire 14 Abbreviated New Drug Applications (ANDAs) from Dr Reddy's Laboratories for an undisclosed amount. The acquisition will be funded through the IPO proceeds.

Senores Pharmaceuticals Ltd shares listed with a premium of over 53% on the BSE and NSE. The IPO received strong investor participation, with a subscription of 93.69 times.

Senores Pharmaceuticals IPO received 93.69 times subscription on the final day of bidding. The IPO, valued at Rs 582 crore, saw strong investor participation across all categories.

Senores Pharmaceuticals' IPO received 13.88 times subscription on Day 2, with strong demand from retail and institutional investors. The IPO will conclude on December 24.

Senores Pharmaceuticals IPO received bids for 1.51 crore shares on Day 1, exceeding the offer size by 1.78 times. RIIs portion fetched 7.19 times subscription while the QIBs quota got subscribed...

Senores Pharmaceuticals raises Rs 261 crore from anchor investors ahead of its IPO. The IPO opens on December 20 and closes on December 24. Read more.

Senores Pharmaceuticals IPO opens on December 20th, with a price band of Rs 372-391 per share. The IPO will raise Rs 582 crore, with proceeds used for manufacturing facility expansion, working...

Senores Pharmaceuticals and Sagility India receive Sebi's approval to launch IPOs, while Bombay Dyeing's rights issue document is returned. Read more about the details of the IPOs and the...

Senores Pharmaceuticals files IPO papers with Sebi to raise Rs 500 crore, aiming to expand its US operations and set up a new manufacturing facility.